AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Kawamoto, T Shoda, J Irimura, T Miyahara, N Furukawa, M Ueda, T Asano, T Kano, M Koike, N Fukao, K Tanaka, N Todoroki, T
Citation: T. Kawamoto et al., Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder, CLIN CANC R, 7(5), 2001, pp. 1333-1342

Authors: Shoda, J Oda, K Suzuki, H Sugiyama, Y Ito, K Cohen, DE Feng, L Kamiya, J Nimura, Y Miyazaki, H Kano, M Matsuzaki, Y Tanaka, N
Citation: J. Shoda et al., Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi, HEPATOLOGY, 33(5), 2001, pp. 1194-1205

Authors: Todoroki, T Kawamoto, T Koike, N Fukao, K Shoda, J Takahashi, H
Citation: T. Todoroki et al., Treatment strategy for patients with middle and lower third bile duct cancer, BR J SURG, 88(3), 2001, pp. 364-370

Authors: Itoh, S Matsuzaki, Y Kimura, T Ikegami, T Shoda, J Fujiwara, M Tanaka, N
Citation: S. Itoh et al., Cytokine profile of liver-infiltrating CD4(+) T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction, J GASTR HEP, 15(4), 2000, pp. 443-451

Authors: Matsuzaki, Y Sato, M Saito, Y Karube, M Doy, M Shoda, J Abei, M Tanaka, N Hadama, T Kinoshita, M
Citation: Y. Matsuzaki et al., The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study (vol 18, pg 397, 1999), J EXP CL C, 19(1), 2000, pp. 125-125

Authors: Itoh, S Matsuzaki, Y Kimura, T Unno, R Ikegami, T Shoda, J Doy, M Fujiwara, M Tanaka, N
Citation: S. Itoh et al., Suppression of hepatic lesions in a murine graft-versus-host reaction by antibodies against adhesion molecules, J HEPATOL, 32(4), 2000, pp. 587-595

Authors: Nakajima, M Yamato, S Shimada, K Sato, S Kitagawa, S Honda, A Miyamoto, J Shoda, J Ohya, M Miyazaki, H
Citation: M. Nakajima et al., Assessment of drug concentrations in tears in therapeutic drug monitoring:I. Determination of valproic acid in tears by gas chromatography/mass spectrometry with EC/NCI mode, THER DRUG M, 22(6), 2000, pp. 716-722

Authors: Yoshida, T Honda, A Matsuzaki, Y Shoda, J Abei, M Tanaka, N Osuga, T
Citation: T. Yoshida et al., Plasma levels of mevalonate and 7 alpha-hydroxy-4-cholesten-3-one in chronic liver disease, J GASTR HEP, 14(2), 1999, pp. 150-155

Authors: Matsuzaki, Y Sato, M Saito, Y Karube, M Doy, M Shoda, J Abei, M Tanaka, N Hadama, T Kinoshita, M
Citation: Y. Matsuzaki et al., The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study, J EXP CL C, 18(3), 1999, pp. 379-389

Authors: Tomida, S Abei, M Yamaguchi, T Matsuzaki, Y Shoda, J Tanaka, N Osuga, T
Citation: S. Tomida et al., Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: Acohort analysis, HEPATOLOGY, 30(1), 1999, pp. 6-13

Authors: Shoda, J Kano, M Asano, T Irimura, T Ueda, T Iwasaki, R Furukawa, M Kamiya, J Nimura, Y Todoroki, T Matsuzaki, Y Tanaka, N
Citation: J. Shoda et al., Secretory low-molecular-weight phospholipases A(2) and their specific receptor in bile ducts of patients with intrahepatic calculi: Factors of chronic proliferative cholangitis, HEPATOLOGY, 29(4), 1999, pp. 1026-1036

Authors: Honda, A Salen, G Shefer, S Batta, AK Honda, M Xu, GR Tint, GS Matsuzaki, Y Shoda, J Tanaka, N
Citation: A. Honda et al., Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7 alpha-hydroxylase and 27-hydroxylase activities in rat liver, J LIPID RES, 40(8), 1999, pp. 1520-1528

Authors: Ikegami, T Matsuzaki, Y Shoda, J Kano, M Hirabayashi, N Tanaka, N
Citation: T. Ikegami et al., The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A(2) expressionin colonic tissue, CANCER LETT, 134(2), 1998, pp. 129-139
Risultati: 1-13 |